KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Daily Values

Growth Metrics

AbbVie (ABBV) Property, Plant & Equipment (Gross) (2012 - 2025)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Gross) (Qtr)
1	Novartis Ag	107,124,802.25 Bn	107,124,802.25 Bn	-	-
2	Eli Lilly	969.00 Bn	963.72 Bn	16.22 Bn	-
3	Johnson & Johnson	539.46 Bn	517.41 Bn	15.96 Bn	54.70 Bn
4	AbbVie	376.92 Bn	367.57 Bn	10.78 Bn	-
5	Merck	285.00 Bn	279.35 Bn	12.09 Bn	-
6	Amgen	177.58 Bn	165.55 Bn	5.87 Bn	-
7	Gilead Sciences	163.22 Bn	155.50 Bn	5.52 Bn	8.42 Bn
8	Pfizer	145.86 Bn	133.09 Bn	-1.21 Bn	-
9	Bristol Myers Squibb	111.90 Bn	101.44 Bn	8.07 Bn	13.09 Bn
10	Gsk	88.34 Bn	83.66 Bn	-	-

Historic Data

Download Data 🔒

Date	Value
Dec 31, 2025	13.53 Bn
Dec 31, 2025	13.53 Bn
Dec 31, 2024	12.27 Bn
Dec 31, 2024	12.27 Bn
Dec 31, 2023	11.64 Bn
Dec 31, 2023	11.64 Bn
Dec 31, 2022	10.99 Bn
Dec 31, 2022	10.99 Bn
Dec 31, 2021	10.73 Bn
Dec 31, 2021	10.73 Bn
Dec 31, 2020	10.86 Bn
Dec 31, 2020	10.86 Bn
Dec 31, 2019	8.19 Bn
Dec 31, 2019	8.19 Bn
Dec 31, 2018	8.40 Bn
Dec 31, 2018	8.40 Bn
Dec 31, 2017	8.07 Bn
Dec 31, 2017	8.07 Bn
Dec 31, 2016	7.53 Bn
Dec 31, 2016	7.53 Bn
Jun 30, 2016	7.60 Bn
Jun 30, 2016	7.60 Bn
Mar 31, 2016	7.49 Bn
Mar 31, 2016	7.49 Bn
Dec 31, 2015	7.33 Bn
Dec 31, 2015	7.33 Bn
Sep 30, 2015	7.28 Bn
Sep 30, 2015	7.28 Bn
Jun 30, 2015	7.17 Bn
Jun 30, 2015	7.17 Bn
Mar 31, 2015	6.99 Bn
Mar 31, 2015	6.99 Bn
Dec 31, 2014	7.11 Bn
Dec 31, 2014	7.11 Bn
Sep 30, 2014	7.06 Bn
Sep 30, 2014	7.06 Bn
Dec 31, 2013	6.91 Bn
Dec 31, 2013	6.91 Bn
Sep 30, 2013	6.79 Bn
Sep 30, 2013	6.79 Bn
Jun 30, 2013	6.65 Bn
Jun 30, 2013	6.65 Bn
Mar 31, 2013	6.55 Bn
Mar 31, 2013	6.55 Bn
Dec 31, 2012	6.54 Bn
Dec 31, 2012	6.54 Bn